- Home
- ISTR vs GNLX Comparison
ISTR vs GNLX Comparison
Compare ISTR & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISTR
- GNLX
- Stock Information
- Founded
- ISTR 2006
- GNLX 2001
- Country
- ISTR United States
- GNLX United States
- Employees
- ISTR N/A
- GNLX N/A
- Industry
- ISTR Major Banks
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- ISTR Finance
- GNLX Health Care
- Exchange
- ISTR Nasdaq
- GNLX Nasdaq
- Market Cap
- ISTR 225.8M
- GNLX 184.4M
- IPO Year
- ISTR 2014
- GNLX 2023
- Fundamental
- Price
- ISTR $18.56
- GNLX $4.81
- Analyst Decision
- ISTR Hold
- GNLX Strong Buy
- Analyst Count
- ISTR 1
- GNLX 4
- Target Price
- ISTR $21.00
- GNLX $18.25
- AVG Volume (30 Days)
- ISTR 33.7K
- GNLX 331.4K
- Earning Date
- ISTR 01-23-2025
- GNLX 03-31-2025
- Dividend Yield
- ISTR 2.26%
- GNLX N/A
- EPS Growth
- ISTR 20.71
- GNLX N/A
- EPS
- ISTR 2.04
- GNLX N/A
- Revenue
- ISTR $86,316,000.00
- GNLX $8,000.00
- Revenue This Year
- ISTR N/A
- GNLX N/A
- Revenue Next Year
- ISTR $11.06
- GNLX N/A
- P/E Ratio
- ISTR $9.10
- GNLX N/A
- Revenue Growth
- ISTR 3.92
- GNLX N/A
- 52 Week Low
- ISTR $14.60
- GNLX $1.60
- 52 Week High
- ISTR $24.81
- GNLX $8.67
- Technical
- Relative Strength Index (RSI)
- ISTR 35.20
- GNLX 58.52
- Support Level
- ISTR $18.52
- GNLX $4.62
- Resistance Level
- ISTR $19.57
- GNLX $5.76
- Average True Range (ATR)
- ISTR 0.50
- GNLX 0.57
- MACD
- ISTR 0.03
- GNLX -0.03
- Stochastic Oscillator
- ISTR 15.84
- GNLX 59.96
About ISTR Investar Holding Corporation
Investar Holding Corp is a us-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.